Error: Could not add to watchlist. X

BB Adamant Global Biotech

+ Watchlist
ADGLBIA:SW
3,390.93
CHF
49.38
1.44%
As of 12:20:00 ET on 09/03/2015.
Fund Type
Open-End Fund
52Wk Range
2,610.00 - 4,046.27
1 Yr Return
20.71%
YTD Return
3.53%
Previous Close
3,440.31
52Wk Range
2,610.00 - 4,046.27
1 Yr Return
20.71%
YTD Return
3.53%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 09/03/2015)
3,390.93
Total Assets (m CHF) (on 09/03/2015)
148.830
Inception Date
10/15/2010
Last Dividend (on 12/05/2012)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
2.50%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.81%
Expense Ratio
1.84%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 37.00 k 13.86 m 8.42
Gilead Sciences Inc 120.00 k 12.71 m 7.72
Celgene Corp 115.00 k 12.42 m 7.54
Regeneron Pharmaceuticals Inc 24.40 k 11.80 m 7.17
Amgen Inc 76.00 k 11.20 m 6.81
Mylan NV 110.00 k 7.54 m 4.58
Vertex Pharmaceuticals Inc 60.00 k 7.26 m 4.41
Illumina Inc 37.00 k 7.19 m 4.37
Kite Pharma Inc 135.00 k 7.02 m 4.27
Isis Pharmaceuticals Inc 100.00 k 6.35 m 3.86
Profile
BB Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050